Trademark: 88481190
Status Date
Tuesday, March 16, 2021
Filing Date
Thursday, June 20, 2019
Abandoned Date
Tuesday, March 16, 2021
5 pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparation for T Cell therapy; biological preparations for the treatment of cancer and tumors
Jan 12, 2023
Case Assigned To Intent To Use Paralegal
Apr 2, 2021
Abandonment Notice Mailed - After Ex Parte Appeal
Mar 16, 2021
Abandonment - After Ex Parte Appeal
Mar 16, 2021
Exparte Appeal Terminated
Feb 3, 2021
Exparte Appeal Dismissed - Failure To File Brief
Nov 19, 2020
Notification Of Action Denying Req For Recon E-Mailed
Nov 19, 2020
Action Denying Req For Recon E-Mailed
Nov 19, 2020
Action Continuing Final - Completed
Nov 18, 2020
Divisional Processing Complete
Sep 3, 2020
Divisional Request Received
Nov 18, 2020
Case Assigned To Intent To Use Paralegal
Oct 29, 2020
Case Assigned To Intent To Use Paralegal
Oct 7, 2020
Ex Parte Appeal-Instituted
Oct 7, 2020
Jurisdiction Restored To Examining Attorney
Oct 7, 2020
Exparte Appeal Received At Ttab
Oct 1, 2020
Teas/Email Correspondence Entered
Sep 30, 2020
Correspondence Received In Law Office
Sep 30, 2020
Teas Request For Reconsideration Received
Sep 3, 2020
Teas Request To Divide Received
Apr 8, 2020
Notification Of Final Refusal Emailed
Apr 8, 2020
Final Refusal E-Mailed
Apr 8, 2020
Final Refusal Written
Mar 18, 2020
Teas/Email Correspondence Entered
Mar 18, 2020
Correspondence Received In Law Office
Mar 18, 2020
Teas Response To Office Action Received
Sep 19, 2019
Notification Of Non-Final Action E-Mailed
Sep 19, 2019
Non-Final Action E-Mailed
Sep 19, 2019
Non-Final Action Written
Sep 12, 2019
Assigned To Examiner
Jun 30, 2019
New Application Office Supplied Data Entered
Jun 24, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
